Daily News Podcast

Heart failure and sacubiril/valsartan


 

A practice-changing study on in-hospital initiation of sacubitril-valartan finds that the practice is safe and effective in acute decompensated heart failure. Also today, concussion or TBI early in life is linked to suicide risk later, revised cholesterol guidelines veer toward personalized risk assessment, and sibling violence is the most common form of family violence.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

FDA approves sufentanil
MDedge Hematology and Oncology
CMS pulls back on E/M payment proposal
MDedge Hematology and Oncology
Most nonemergent diagnoses can’t be predicted
MDedge Hematology and Oncology
Hypertension and CVD risk for young adults
MDedge Hematology and Oncology
Biomarkers and concussions
MDedge Hematology and Oncology
Portable hematology analyzer gets FDA nod
MDedge Hematology and Oncology
Samuel Shem: Part II
MDedge Hematology and Oncology
Trump rule and ACA contraception
MDedge Hematology and Oncology
How to slash colorectal surgery infection rates
MDedge Hematology and Oncology
‘Organoid technology’ poised to transform cancer care
MDedge Hematology and Oncology